Metropolitan Life Insurance Company (MetLife)’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.47K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $8.41K | Hold |
|
|||||
|
2023
Q2 | $10K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $43.1K | Sell |
|
|||||
|
2021
Q3 | $48.1K | Sell |
|
|||||
|
2021
Q2 | $110K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $164K | Sell |
|
|||||
|
2017
Q2 | $182K | Hold |
|
|||||
|
2017
Q1 | $199K | Buy |
|
|||||
|
2016
Q4 | $182K | Sell |
|
|||||
|
2016
Q3 | $227K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $185K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $223K | Buy |
|